Shares of Dr Reddys Laboratories experienced a decline of 0.67% to Rs 1228.00 during today's trading session, accompanied by high trading volume. This movement has drawn the attention of investors and market analysts, as the stock is a component of both the NIFTY 50 and NIFTY 100 indices.
The financial performance of Dr Reddys Laboratories offers insights into the company's current stock behavior. Recent financial data reveals the following trends:
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | 32,643 | 28,011 | 24,669 | 21,545 | 19,047 |
| Other Income | 1,097 | 894 | 1,055 | 484 | 291 |
| Total Income | 33,741 | 28,905 | 25,725 | 22,029 | 19,338 |
| Total Expenditure | 25,800 | 21,548 | 19,570 | 18,942 | 16,406 |
| EBIT | 7,940 | 7,357 | 6,154 | 3,086 | 2,932 |
| Interest | 282 | 171 | 142 | 95 | 97 |
| Tax | 1,954 | 1,623 | 1,541 | 878 | 931 |
| Net Profit | 5,703 | 5,563 | 4,470 | 2,112 | 1,903 |
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | 8,528 | 8,381 | 8,038 | 7,696 | 7,113 |
| Other Income | 522 | 150 | 307 | 187 | 197 |
| Total Income | 9,050 | 8,531 | 8,345 | 7,883 | 7,311 |
| Total Expenditure | 6,985 | 6,579 | 6,358 | 5,946 | 5,650 |
| EBIT | 2,065 | 1,951 | 1,987 | 1,936 | 1,661 |
| Interest | 65 | 81 | 75 | 59 | 59 |
| Tax | 418 | 470 | 575 | 490 | 295 |
| Net Profit | 1,581 | 1,400 | 1,335 | 1,386 | 1,306 |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Operating Activities | 4,642 | 4,543 | 5,887 | 2,810 | 3,570 |
| Investing Activities | -5,102 | -4,028 | -4,137 | -2,638 | -2,266 |
| Financing Activities | 1,185 | -376 | -2,686 | -242 | -29 |
| Others | 22 | -5 | 28 | 73 | 11 |
| Net Cash Flow | 748 | 132 | -907 | 3 | 1,285 |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Share Capital | 83 | 83 | 83 | 83 | 83 |
| Reserves & Surplus | 33,466 | 28,171 | 23,202 | 19,129 | 17,558 |
| Current Liabilities | 13,033 | 9,588 | 8,572 | 9,765 | 8,103 |
| Other Liabilities | 2,843 | 1,021 | 426 | 768 | 871 |
| Total Liabilities | 49,426 | 38,863 | 32,285 | 29,746 | 26,616 |
| Fixed Assets | 19,378 | 11,294 | 9,701 | 8,867 | 9,210 |
| Current Assets | 25,018 | 24,805 | 20,425 | 17,782 | 14,550 |
| Other Assets | 5,030 | 2,763 | 2,157 | 3,097 | 2,855 |
| Total Assets | 49,426 | 38,863 | 32,285 | 29,746 | 26,616 |
| Contingent Liabilities | 0 | 2,091 | 997 | 936 | 1,077 |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 64.22 | 335.22 | 271.47 | 131.57 | 117.67 |
| Diluted Eps (Rs.) | 64.13 | 334.59 | 270.90 | 131.21 | 117.34 |
| Book Value /Share (Rs.) | 402.27 | 1,693.93 | 1,397.73 | 1,154.59 | 1,060.20 |
| Dividend/Share (Rs.) | 8.00 | 40.00 | 40.00 | 30.00 | 25.00 |
| P/E (x) | 17.82 | 3.67 | 3.41 | 6.53 | 7.68 |
| P/B (x) | 2.84 | 3.63 | 3.31 | 3.73 | 4.26 |
| EV/EBITDA (x) | 10.11 | 11.62 | 10.32 | 17.01 | 18.20 |
| P/S (x) | 2.92 | 3.67 | 3.12 | 3.33 | 3.94 |
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
